The most common causative agents include *Staphylococcus aureus*, both methicillin-sensitive and methicillin-resistant strains, as well as other bacteria such as *Streptococcus*, *Pseudomonas*, and Gram-negative rods. Infections often originate from adjacent soft tissue wounds, hematogenous spread (via the bloodstream), or complications from orthopedic procedures or medical devices, such as intravenous catheters or prosthetic joints. Risk factors include diabetes, vascular insufficiency, immunosuppression, and prior bone trauma or surgery.
Symptoms of acute osteomyelitis typically include localized pain, swelling, warmth, and tenderness over the affected bone, along with systemic signs such as fever, chills, and fatigue. Chronic osteomyelitis may present with persistent pain, drainage from a sinus tract, and possible bone deformity or nonunion of fractures. Diagnosis involves clinical evaluation, laboratory tests (such as complete blood count and erythrocyte sedimentation rate), imaging studies (X-rays, MRI, or CT scans), and sometimes bone biopsy for culture identification.
Treatment typically combines antibiotic therapy, tailored to the causative organism and its susceptibility, with surgical intervention in severe or refractory cases. Antibiotics may be administered intravenously initially, followed by oral therapy if the infection responds well. Surgical debridement or removal of infected bone or foreign bodies may be necessary to eradicate the infection and promote healing. In chronic cases, repeated surgical procedures or long-term antibiotic suppression may be required.
Complications of untreated or inadequately treated osteomyelitis include bone destruction, pathological fractures, sepsis, and the formation of abscesses or fistulas. Early diagnosis and appropriate treatment are critical to preventing these outcomes and improving patient prognosis. Prevention strategies focus on proper wound care, infection control in medical settings, and prompt treatment of secondary infections.